BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

OncoSec Medical Inc. 

200 South Virginia Street
8th Floor
Reno  Nevada  89501  U.S.A.
Phone: 775-562-0504 Fax: n/a


SEARCH JOBS




Industry
Medical Device






 Company News
OncoSec Medical Inc. Announces New Phase II Trial In Head And Neck Cancer Using ImmunoPulse 12/9/2014 2:14:51 PM
OncoSec Medical Inc. Announces First Quarter Results For Fiscal Year End 2015 12/8/2014 11:21:50 AM
OncoSec Medical Inc. Reports Positive Top-Line Six-Month Primary Endpoint Data From Phase II Melanoma Trial Of ImmunoPulse Monotherapy 12/5/2014 12:10:31 PM
OncoSec Medical Inc. To Host Corporate Update Conference Call On December 9, 2014 12/5/2014 10:59:32 AM
OncoSec Medical Inc. Says ImmunoPulse Tumor Drug Met Phase II Endpoints 12/5/2014 10:36:30 AM
OncoSec Medical Inc. Reports ImmunoPulse May Prolong Survival Based On Analysis Of Long-Term Survival Data From Phase I Study In Melanoma 12/5/2014 9:36:50 AM
OncoSec Medical Inc. Collaborates With PerkinElmer, Inc. (PKI) And University of California, Los Angeles (UCLA) To Evaluate Patient-Selection Biomarker In Immunotherapy 12/2/2014 11:52:57 AM
OncoSec Medical Inc. To Present At Two Events In December 12/1/2014 3:01:48 PM
Nature Publication Co-Authored By Robert H. Pierce, Chief Scientific Officer, OncoSec Medical Inc. 12/1/2014 12:39:07 PM
University of California, San Francisco (UCSF) And OncoSec Medical Inc. Collaborate To Evaluate Investigational Combination Of ImmunoPulse And Anti-PD-1 Treatment 11/25/2014 10:36:55 AM
12345678910...